|
Market Closed -
Nasdaq
06:00:00 22/08/26 am AEST
|
5-day change | 1st Jan Change | ||
| 146.12 USD | +1.87% |
|
+5.61% | +19.05% |
| 19/08 | Gilead Sciences Insider Sold Shares Worth $3,853,908, According to a Recent SEC Filing | MT |
| 12/08 | Global drugmakers invest billions to boost US presence | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 181B | - | ||||
| 1,119B | |||||
| 651B | - | - | - | ||
| 468B | |||||
| 374B | |||||
| 302B |
- Stock Market
- Stocks
- GILD Stock
- Charts Gilead Sciences, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
